Advertisement

2008 update of the guideline: early detection of breast cancer in Germany

  • Ute-Susann Albert
  • Helmut Altland
  • Volker Duda
  • Jutta Engel
  • Max Geraedts
  • Syvia Heywang-Köbrunner
  • Dieter Hölzel
  • Eva Kalbheim
  • Michael Koller
  • Klaus König
  • Rolf Kreienberg
  • Thorsten Kühn
  • Annette Lebeau
  • Irmgard Nass-Griegoleit
  • Werner Schlake
  • Rita Schmutzler
  • Ingrid Schreer
  • Hilde Schulte
  • Rüdiger Schulz-Wendtland
  • Uwe Wagner
  • Ina Kopp
Original Paper

Abstract

Introduction

The goal of the 2008 updated guideline: early detection of breast cancer in Germany is to support physicians as well as healthy and affected women in the decision-making process involved in the diagnostic chain for the early detection of breast cancer by providing them with evidence- and consensus-based recommendations. The updated guideline replaces the guideline issued in 2003.

Materials and methods

The guideline forms the basis for developing an effective and efficient national early breast cancer detection program that meets the standards set by the Council of Europe and WHO for cancer control programs. The guideline presents the current, evidence- and consensus-based state of scientific knowledge in a multidisciplinary approach for the entire diagnostic chain, consisting of history taking and risk consultation, information on health behavior, clinical breast examination, diagnostic imaging, image-guided percutaneous tissue-acquisition techniques, open surgical excisional biopsy and pathomorphological tissue evaluation. The guideline recommends a set of quality indicators to assure resource availability, performance quality and outcomes enhancing total quality management for early breast cancer diagnosis.

Conclusion

Currently, early detection of breast cancer offers the most promising possibility to optimize the diagnosis and treatment of breast cancer and, as a result, reduce breast cancer mortality and improve health related quality of life in women.

Keywords

Breast cancer Early detection Screening Guideline Quality indicators 

Notes

Acknowledgments

The project: Update of the Guideline: Early Detection of Breast Cancer in Germany—Model Project for the Updating of Stage-3-Guidelines in Germany, Funding Code: 107374 was funded by the German Cancer Aid and the German Society of Senology and was developed independent of any funding from government or industry. Individuals contributing to the Guideline signed declarations on possible conflicts of interests. We thank A. Rost and I. Striesow for secretarial and organizational support.

References

  1. Albert US (ed) (2008) Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland 1.Aktualisierung 2008, 1st edn. Zuckschwerdt, MuenchenGoogle Scholar
  2. Albert US, Schulz KD, The members of the guideline steering committee and the chair persons of the task force groups (2004) Short version of the guideline: early detection of breast cancer in Germany. J Cancer Res Clin Oncol 130:527–536. doi: 10.1007/s00432-004-0558-7 PubMedCrossRefGoogle Scholar
  3. Albert US, Schulz KD, Alt D, Beck V, Doherty J, Holsteg K et al (2003) Eine Leitlinie für Leitlinien: die methodische Entwicklung und Anwendung der Leitlinie Fraueninformation. Zentralbl Gynakol 125:484–493 (AWMF Reg. Nr.: 077-002; http://www.awmf-leitlinien.de)
  4. Albert US, Schulz KD, Kopp I (2007) Leitlinien-Methodenreport: Aktualisierung der Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland 2007, konsultierte Fassung Version 1.1 edn. http://www.awmf-leitlinien.de, Marburg
  5. Amendoeira I, Apostolikas N, Bellocq J, Bianchi S, Boecker W, Borisch B, Elston C, Eusebi V, Faverly D, Heikkila P, Holland R, Kerner H, Kulka J, Jacquermier J, Lacerda M, Martinez-Penuela J, De Miquel C, Nordgren H, Peterse JL, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafari B, Tanous A, Thorstenson S, Zozoya E, Wells C (2006a) Quality assurance guidelines for pathology: Cytological and histological non-operative procedures. In: Wells CA (ed) European guidelines for quality assurance in breast cancer screening and diagnosis, 4 edn. Office for Official Publications of the European Communities, Luxembourg, pp 221–256Google Scholar
  6. Amendoeira I, Apostolikas N, Bellocq J, Bianchi S, Boecker W, Borisch B et al. 0, Elston C, Eusebi V, Faverly D, Heikkila P, Holland R, Kerner H, Kulka J, Jacquermier J, Lacerda M, Martinez-Penuela J, De Miquel C, Nordgren H, Peterse JL, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafari B, Tanous A, Thorstenson S, Zozoya E, Wells C (2006b) Quality assurance guidelines for pathology: open biopsy and resection specimens. In: Wells CA (ed) European guidelines for quality assurance in breast cancer screening and diagnosis, 4 edn. Office for Official Publications of the European Communities, Luxembourg, pp 257–311Google Scholar
  7. American College of Radiology (ACR) (2003) Breast Imaging reporting and data system (BIRADS™), 4th edn. American College of Radiology, Reston, VAGoogle Scholar
  8. Ball C, Sackett D, Philipps B, Haynes B, Straus S, Dawes M (2001) Oxford-Centre for Evidence-based Medicine Levels of Evidence (2001). http://www.cebm.net/level_of_evidence.asp Zugriff: 08042007
  9. Brenner H, Stegmaier C, Ziegler H (2005) Verbesserte Langzeitüberlebensraten von Krebspatienten. Die unterschätzten Fortschritte der Onkologie. Dtsch Arztebl 102:2628–2633Google Scholar
  10. Brett J, Bankhead C, Henderson B, Watson E, Austoker J (2005) The psychological impact of mammographic screening. A systematic review. Psychooncology 14:917–938. doi: 10.1002/pon.904 PubMedCrossRefGoogle Scholar
  11. Bundesärztekammer (BÄK) Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Kassenärztliche Bundesvereinigung (KBV) (2007) Nationales Programm für VersorgungsLeitlinien. Methoden-Report, 3rd edn. Berlin, http://www.versorgungsleitlinie.de
  12. Calman K, Hine D, Peto R, Boreham J, Clarke M, Purushotham A, Pain S, Miles D (2002) NICE: Improving outcomes in breast cancer. NICE, LondonGoogle Scholar
  13. Carlson R, Anderson B, Burstein H (2005) NCCN Breast Cancer Clinical practice guidelines in Oncology. National Comprehensivie Cancer Network (http://www.nccn.org), USA
  14. Crystal P, Koretz M, Shcharynsky S, Makarov V, Strano S (2004) Accuracy of sonographically guided 14-gauge core-needle biopsy: result of 715 consecutive breast biopsies with at least two-year follow-up of benign lesions. J Clin Ultrasound 33:47–51. doi: 10.1002/jcu.20089 CrossRefGoogle Scholar
  15. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. 1. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403–410. doi: 10.1111/j.1365-2559.1991.tb00229.x PubMedCrossRefGoogle Scholar
  16. Encke A, Kopp I, Selbmann H, Hoppe J, Köhler A, Ollenschläger G (2006) Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Ärztliches Zentrum für Qualität in der Medizin (ÄZQ), (Hrsg) (2006) Deutsches Instrument zur methodischen Bewertung von Leitlinien: DELBI. Dt Ärztebl 102:A1912–A1913Google Scholar
  17. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2006) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18(3):581–592. doi: 10.1.093/annonc/imd498 CrossRefGoogle Scholar
  18. Fishman J, Milikowski C, Ramsinghani R, Velasquez M, Aviram G (2003) US-guided core-needle biopsy of the breast: how many specimens are necessary? Radiology 226:779–782PubMedCrossRefGoogle Scholar
  19. Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V.und das Robert Koch Institut (2006) Krebs in Deutschland - Häufigkeiten und Trends, 5. überarbeitete, aktualisierte Auflage edn. RoBo Print, Riegelsberg, SaarbrückenGoogle Scholar
  20. Gotzsche PC, Nielsen M (2006) Screening for breast cancer with mammography. Cochrane Database Syst Rev 18(4):CD001877. doi: 10.1002/14651858.CD001877.pub2 Google Scholar
  21. Harvey JM, Clark GM, Osborne CK, Allred DC (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17:1474–1481PubMedGoogle Scholar
  22. Hoffmann W, Latza U, Terschüren C, Berger K, Bergmann M, Dahl A et al. (2004) Leitlinien und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP) - Langversion, 2.mit Änderungen nach Evaluation edn. Arbeitsgruppe Epidemiologischer Methoden der Deutschen Arbeitsgemeinschaft für Epidemiologie (DAE); Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (GMDS); Deutsche Gesellschaft für Sozialmedizin und Prävention (DGSMP); Deutsche Regionen der Internationalen Biometrischen Gesellschaft (DR-IBS); 1.ed: Kurth BM; Hense HW; Hoffmann W; AhrensW; Babitsch B; Becher H; Blettner M; Brasche S; Brenner H; Enderlein G; Greiser KH; Jahn I; Jöckel KH; Kirschner W; Kohlmann T; Liese A; Möhner M; Mueller U; Reintjes R; Stang A; Wyst M: http://www.medweb.uni-muenster.de/institute/epi/dae/vorstand.html, Münster
  23. ICSI (2005) Diagnosis of breast disease—guideline ICSI, update 2005. ICSI, (http://www.icsi.org)
  24. Katalinic A, Bartel C, Raspe H, Schreer I (2007) Beyond mammography screening: quality assurance in breast cancer diagnosis. Br J Cancer 96:157–161PubMedCrossRefGoogle Scholar
  25. Kopp I, Encke A, Lorenz W (2002) Leitlinien als Instrument der Qualitätssicherung in der Medizin. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 45:223–233. doi: 10.1007/s00103-002-0378-3 CrossRefGoogle Scholar
  26. Lorenz W, Ollenschläger G, Geraedts M, Gerlach F, Gangjour A, Helou A et al (2001) Das Leitlinien Manual:Entwicklung und Implementierung von Leitlinien in der Medizin. ZaeFQ 95:1–84Google Scholar
  27. Madjar H, Ohlinger R, Mundinger A, Watermann D, Frenz J, Bader W et al (2006) BI-RADS analoge DEGUM Kriterien von Ultraschallbefunden der Brust - Konsensus des Arbeitskreises Mammosonographie der DEGUM. Ultraschall Med 27:374–379. doi: 10.1055/s-2006-926943 PubMedCrossRefGoogle Scholar
  28. NBCC (2004a) Clinical practice guidelines for the management and support of younger women with breast cancer, 1st edn. National Health and Medical Research Council (NHMRC), (http://www.nbcc.org.au), Camperdown, NSW
  29. NBCC (2004b) Position Statement early detection of breast cancer. In: NBCC (ed) National Health and Medical Research Council, (http://www.nbcc.org.au), Canberra
  30. NBCC (2006) The investigation of a new breast syptom—a guide for GP. NBCC, http://www.nbcc.org.au, Australia
  31. National Breast Cancer Center (NBCC) (2001) Clinical practice guidelines for the management of early breast cancer, i Soruce edn. National Breast Cancer Center (NBCC) (http://www.nbcc.org.au), Australia
  32. National Breast Cancer Centre (NBCC) (2006) Evidence relevant to guidelines for the investigation of breast symptoms, 2nd edn. National Breast Cancer Centre, (http://www.nbcc.org.au), Camperdown, Australia
  33. National Comprehensive Cancer Network (NCCN) (2006) Breast Cancer. NCCN Clinical Practice Guidelines in Oncology, http://www.nccn.org, USA
  34. National Comprehensive Cancer Network (NCCN) (2007a) Breast cancer screening and diagnosis guidelines. NCCN Clinical Practice Guidelines in Oncology, (http://www.nccn.org), USA
  35. National Comprehensive Cancer Network (NCCN) (2007b) Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Clinical Practice Guidelines in Oncology edn. Clinical Practice Guidelines in Oncology, (http://www.nccn.org), USA
  36. National Quality Management Committee of BreastScreen Australia (2004) Breastscreen Australia–National Accrediation Standards. 2004Google Scholar
  37. NICE NCCfPC (2006c) Familial breast cancer - The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care Update July 2006. NICE, http://www.nice.org.uk/CG041, UK
  38. NHMRC (1999) Psychosocial clinical practice guideline. NHMRC, (http://www.nhmrc.health.gov.au), Australia
  39. NHS Centre for Reviews, Dissemination (2000) Effective health care: Informing, communicating and sharing decision with people who have cancer. Latimer Trend & Company Ltd, PlymouthGoogle Scholar
  40. NHSBSP (2001) Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening (vol NHSBSP Publication No. 50). NHS Cancer Screening Programmes, SheffieldGoogle Scholar
  41. NICE (2005) NICE clinical guideline no 27: referral guidelines for suspected cancer. NICE, http://www.nice.org.uk/CG027, UK
  42. NICE (2006a) Breast cancer: diagnosis and treatment. NICE, (http://www.nice.org.uk), UK
  43. NICE (2006b) Image-guided vacuum-assisted excision biopsy of benign breast lesions. NICE, http://www.nice.org.uk/IPG156, UK
  44. Nothacker M, Lelgemann M, Giersiepen K, Weinbrenner S (2007) Evidenzbericht 2007 zur S-3-Leitlinie Brustkrebsfrüherkennung in Deutschland, version 1.00 edn. Ärztliches Zentrum für Qualität in der Medizin (ÄZQ), Band 31 http://www.aezq.de/publikationen0index/schriftenreihe/view, http://www.awmf-leitlinien.de, Berlin
  45. O’Higgins N, Linos DA, Blichert-Toft M, Cataliotti L, de Wol C, Rochard F et al (2006) European guidelines for quality assurance in the surgical management of mammographically detected lesions. In: Perry N, Broeders M, de Wolf C, Toernberg S, Holland R, von Karsa L (eds) European guidelines for quality assurance in breast cancer screening and diagnosis, 4th edn. Office for official publication of the European Communities, Luxembourg, pp 315–320Google Scholar
  46. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L (2006) European guidelines for quality assurance in breast cancer screening and diagnosis, 4th edn. European Communities Publication, LuxembourgGoogle Scholar
  47. Raab-Schlesinger A, Eckel R, Engel J, Sauer H, Löhrs U, Molls M et al (2005) Metastasiertes Mammakarzinom: Keine Lebensverlängerung seit 20 Jahren. Aerzteblatt 102:B2280–B2288Google Scholar
  48. Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138–140PubMedGoogle Scholar
  49. Robert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (Hrsg) (2008) Krebs in Deutschland 2003–2004. Häufigkeiten und Trends, 6. überarbeitet Auflage edn. Druckhaus Berlin-Mitte GmbH, BerlinGoogle Scholar
  50. Schreer I, Katalinic A (2007) Is high quality breast imaging and diagnosis possible in a decentralized system? Breast Care 2:20–24. doi: 10.1159/000099367 CrossRefGoogle Scholar
  51. Schulz KD, Albert US, und die Mitglieder der Arbeitsgruppe “Konzertierte Aktion: Brustkrebs-Früherkennung in Deutschland (2003) Stufe 3 Leitlinie Brustkrebs-Früherkennung in Deutschland, 1 edn. Zuckschwerdt Verlag, MünchenGoogle Scholar
  52. Schwartz G, Veronesi U, Clough K, Dixon J, Fentima I, Heywang-Köbrunner S et al. (2006) Consensus Conference on Breast Conservation. Milan, Italy, 28 April–1 May 2005. Cancer 107:242–250. doi: 10.1002/cncr.21988 Google Scholar
  53. Scottish Intecollegiate Guideline Network (SIGN) (2005) SIGN Scottish Intecollegiate Guideline Network. Management of breast cancer in women. SIGN, (http://www.sign.ac.uk), Edinburgh
  54. Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED et al (1995) Prognostic classification of breast ductal carcinoma-in-situ. Lancet 345:1154–1157. doi: 10.1016/S0140-6736(95)90982-6 PubMedCrossRefGoogle Scholar
  55. Smith R, Saslow D, Sawyer K, Burke W, Costanza M, Evans W et al. Hendrick E, Eyre H, Sener S (2003) American Cancer Society guidelines for breast cancer screening. Update 2003. CA Cancer J Clin 53:141–169 (http://www.caonline.amcancersoc.org/cgi/content/full/53/3/141)
  56. Smith R, Caleffi M, Albert US, Chen T, Duffy S, Franceschi D et al (2006) Breast cancer in limited-resource countries: early detection and access to care. Breast J 12:S16–S26. doi: 10.1111/j.1075-122X.2006.00200.x PubMedCrossRefGoogle Scholar
  57. Sobin L, Wittekind C (2002) UICC. TNM classification of malignant tumours, 6th edn. John Wiley & Sons, Inc. Publication, New YorkGoogle Scholar
  58. The Association of Breast Surgery at BASO, RCoSoE (2005) Guidelines for the management of symptomatic breast disease. Eur J Surg Oncol 31:S1–S21Google Scholar
  59. Wolff A, Hammond M, Schwartz J, Hagerty K, Allred D, Cote R, Dowsett M, Fitzgibbons P, Hanna W, Langer A, McShane L, Paik S, Pegram M, Perez E, Press M, Rhodes A, Sturgeon C, Taube S, Tubbs R, Vance G, vanD V, Wheeler T, Hayes D (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:145. doi: 10.1200/JCO.2007.11.4363 CrossRefGoogle Scholar
  60. WHO (2003) Pathology and genetics of tumours of the breast and female genital organs. In: Tavassoli F, Devilee P (eds) World Health Organization (WHO) classification of tumours. IACR Press, Lyon, pp 9–112Google Scholar
  61. World Health Organization (WHO) (2002) National Cancer Control Programs: policies and managerial guidelines, 2nd edn. Health and Development Networks (HDN), Geneva, ItalyGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Ute-Susann Albert
    • 1
  • Helmut Altland
    • 2
  • Volker Duda
    • 1
  • Jutta Engel
    • 3
  • Max Geraedts
    • 4
  • Syvia Heywang-Köbrunner
    • 5
  • Dieter Hölzel
    • 6
  • Eva Kalbheim
    • 7
  • Michael Koller
    • 8
  • Klaus König
    • 9
  • Rolf Kreienberg
    • 10
  • Thorsten Kühn
    • 11
  • Annette Lebeau
    • 12
  • Irmgard Nass-Griegoleit
    • 13
  • Werner Schlake
    • 14
  • Rita Schmutzler
    • 15
  • Ingrid Schreer
    • 16
  • Hilde Schulte
    • 17
  • Rüdiger Schulz-Wendtland
    • 18
  • Uwe Wagner
    • 1
  • Ina Kopp
    • 19
  1. 1.Faculty of MedicinePhilipps-UniversityMarburgGermany
  2. 2.German Professional Association of RadiologistsSt. AugustinGermany
  3. 3.Munich Tumor RegisterGrosshadern Medical CenterMunichGermany
  4. 4.Public HealthHeinrich-Hein-UniversityDüsseldorfGermany
  5. 5.Mammography Reference CenterMunichGermany
  6. 6.Institute for Medical Data Processing, Biometries and EpidemiologyGrosshadern Medical CenterMunichGermany
  7. 7.German Cancer AidBonnGermany
  8. 8.Center for Clinical StudiesUniversity HospitalRegensburgGermany
  9. 9.German Professional Association of GynecologistsSteinbachGermany
  10. 10.Faculty of MedicineUniversity UlmUlmGermany
  11. 11.Gynecology and Obstetrics Medical CenterEsslingenGermany
  12. 12.Faculty of MedicineInstitute of PathologieHamburgGermany
  13. 13.Women’s Health CoalitionDarmstadtGermany
  14. 14.German Professional Association of PathologistsGelsenkirchenGermany
  15. 15.Faculty of MedicineUniversity of CologneCologneGermany
  16. 16.Faculty of MedicineUniversity Medical Center, Breast CenterKielGermany
  17. 17.German Federal Self-Help Organisation for Women with CancerBonnGermany
  18. 18.Institute for Diagnostic Radiology and Gynecologic RadiologyErlangenGermany
  19. 19.Association of the Scientific Medical SocietiesMarburgGermany

Personalised recommendations